Industrial, Manufacturing & Heavy Industry Market News

Pharmacovigilance market segmentation and industrial overview forecasts to 2027 available in new report

wires

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications.

- Advertising -

The "Global Pharmacovigilance Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by clinical trial phase, service provider, type of method, end user and geography.

The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pharmacovigilance market players and offers key trends and opportunities in the market.

- Advertising -

Increasing cases of adverse drug reactions and increasing consumption of drugs across the globe are expected to fuel the growth of the pharmacovigilance market during the forecast period. Moreover, shift in outsourcing of various activities among pharmaceutical and life science sector is anticipated to offer significant growth opportunities in the market.

Top Dominating Key Players:

  1. 1. Accenture
    2. Bristol-Myers Squibb Company
    3. Linical Accelovance
    4. Cognizant
    5. Covance Inc.
    6. F. Hoffmann-La Roche Ltd.
    7. GlaxoSmithKline plc.
    8. ICON plc
    9. Capgemini (IGATE Corporation)
    10. Novartis AG

Report: https://www.theinsightpartners.com/sample/TIPRE00003127

The global pharmacovigilance market is segmented on the basis of clinical trial phase, service provider, type of method, and end user. Based on clinical trial phase, the market is classified as, Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV.

Similarly, on the basis of service type, the market is categorized as, in-house and contract outsourcing. The pharmacovigilance market is segmented based on type of method such as, spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining.

On the basis of end user, the market is classified as, hospitals, research organizations, and industrial.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pharmacovigilance market based clinical trial phase, service provider, type of method, and end user.

It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmacovigilance market by each region is later sub-segmented by respective countries and segments.

The report covers analysis and forecast of 18 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the pharmacovigilance market in the coming years, owing to the presence of major market players in the region along with the initiatives to reduce the healthcare expenditure as well as sophisticated healthcare infrastructure. Asia Pacific is anticipated to witness significant growth in the market during the forecast period, due to rising adoption of IT in the field of healthcare top offer better services to the patients.

Report: https://www.theinsightpartners.com/sample/TIPRE00003127

Reason to Access:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Pharmacovigilance Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Pharmacovigilance, thereby allowing players to develop effective long term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

News From

The Insight PartnersThe Insight Partners
Category: Technology Business Consultants Company about: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, HealthCare IT and Telecommunication industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.